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Summary
Recent research in the area of carbohydrate food ingredients has shown the efficiency
of oligosaccharides when they are used as prebiotics or biopreservatives. Considering the
former, they have various origins and structures, whereas the latter are described mostly
as oligochitosans or as low molecular mass chitosans. If new manufacturing biotechnolo-
gies have significantly increased the development of these functional food ingredients, the
main drawback limiting their applications is the difficulty to engender specific glycosidic
structures. The present review focuses on the knowledge in the area of food bioactive oli-
gosaccharides and catalogues the processes employed to generate them.
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Introduction
In food industries, as chemical additives are becom-
ing less and less welcome by consumers, there has been
an increasing interest in the use of saccharidic natural
substances known as prebiotic and biopreservative oli-
gosaccharides.
Traditionally, oligosaccharides are defined as poly-
mers of monosaccharides with degrees of polymeriza-
tion (DP) between 2 and 10 (3 and 10 according to the
IUB-IUPAC nomenclature) but DPs up to 20–25 are of-
ten assimilated with them. Prebiotic oligosaccharides are
noncariogenic, nondigestible (NDO) and low calorific
compounds stimulating the growth and development of
gastrointestinal microflora described as probiotic bacte-
ria. It is claimed that these bacteria belonging to Bifido-
bacteria and Lactobacilli have several health-promoting
effects (1,2). Moreover, the recent development of com-
mercial prebiotic oligosaccharides and probiotic bacteria
has led naturally to a new concept, that of symbiotic one,
combining probiotics and prebiotics (3). Paradoxically,
other oligosaccharides and more specifically chitosan oli-
gosaccharides (COS) or low molecular mass chitosans
(LMMC) are described as food additives for their anti-
microbial effects against pathogenic bacteria or fungi (4–6).
Additionally, data suggest that specific COS or LMMC
could also have beneficial effect on the growth of Bifido-
bacteria and Lactobacilli (7,8). Structural features of these
oligomers appear as modulators for their biological ac-
tivities.
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In the current context of functional foods generating
a global market of 33 billion US dollars (9), oligosaccha-
rides could play a major role as functional ingredients
compared to dietary fibers, sugar alcohols, peptides,
probiotics, polyunsaturated fatty acids and antioxidants.
Nonetheless, they will have a very large development in
the future, depending on the viability of their large scale
production. Oligosaccharides have currently two ori-
gins: they can be synthesized by chemical glycosylation
and de novo using glycosidase and glycosyltransferase
activities, or they can derive from chemical, physical or
biological degradation of polysaccharides. As a conse-
quence, this review focuses on the present uses of oligo-
saccharides as nutraceuticals, but also on the recent de-
velopments in the area of their production.
Oligosaccharides As Prebiotics
Presently, standard prebiotics are largely used de-
pending on their putative positive action on the host’s
health. For these reasons, this new class of food ingredi-
ents has been added to human and domestic animals'
foods. Concerning carbohydrates, the term prebiotic may
be ambiguous because a lot of saccharidic compounds
are present in feeding with or without prebiotic action
(dietary fibers for example). In this context, Gibson et al.
(10) established clear criteria for classifying a food ingre-
dient as a prebiotic. Accordingly, a prebiotic oligosac-
charide firstly needs to be resistant to gastric acidity, hy-
drolysis by mammalian enzymes and gastrointestinal
absorption. Secondly, this oligomer has to be fermented
by the intestinal microflora. Thirdly, it stimulates selec-
tively the growth and/or activity of intestinal bacteria
associated with health and wellbeing such as Bifidobac-
teria and Lactobacilli.
We have noticed that the majority of studies focuses
on the in vitro metabolism of prebiotic oligosaccharides,
and the mechanisms operating in vivo need to be eluci-
dated. Uses of simulators of the human intestinal micro-
bial ecosystem (SHIME) could lead to the design of
more effective forms of prebiotics in the future (11). Fur-
thermore, quantification strategies of prebiotic effects are
currently assayed in vitro on faecal batch cultures (12)
and a prebiotic index (PI) has been created (13).
FOS and GOS prebiotics
If some NDOs with prebiotic activities occur natu-
rally in human milk (14) and plants (15), most of them
are synthesised or isolated from plant polysaccharides
such as fructooligosaccharides (FOS), galactooligosaccha-
rides (GOS) or trans-galactooligosaccharides (TGOS), iso-
maltooligosaccharides (IMO), xylooligosaccharides (XOS),
plant cell wall derived polysaccharides and other. At this
time, FOS and GOS are leaders on the world market.
There is little information about the structure-function
relationships of these oligosaccharides apart from the stu-
dies comparing the fermentation properties of commer-
cial products.
The prebiotic effects of FOS or inulin (a mixture of
FOS and polysaccharides) have been investigated by
studying the metabolism of this mixture with DP from 3
up to 40–50 using Bifidobacterium sp. or Lactobacillus sp.
(9,16). We noted a high degree of variability in DP distri-
bution depending on industrial preparations. All FOS con-
sist of a glucose monomer a-(1,2) linked to two (GF2) or
more (GFn) b-(2,1) fructosyl units. Generally, in vitro data
support the selective stimulation of bacterial growth by
FOS and inulin using pure bacterial or/and faecal batch
culture. However, metabolism of pure oligomers with
controlled DP by colonic microflora has not been stud-
ied much even if the presence of fermentable mono- or
disaccharides is well known in commercial preparations
obtained from natural sources (e.g. inulin) or naturally
synthesized from sucrose. In this context, the use of
pure FOS mixtures containing three FOS species (GF2,
GF3 and GF4) led to the identification of only 2 oligosac-
charides (GF2 and GF3) consumed by Lactobacillus strains.
None of the examined strains was able to metabolise the
GF4 species, which suggests an intracellular metabolism
after the FOS transport (17). This transfer has been re-
cognised as mediated by an ATP-dependent transport
system having specificity for a narrow range of sub-
strates (18). Nonetheless, another paradigm is the FOS
degradation by probiotic cell-associated exoglycosidases
and notably b-fructofuranosidases. With this mechanism,
identified in a Bifidobacterium infantis strain, the mono-
saccharides generated are taken up by the bacteria (19).
Using animal models or volunteers fed with aliments
containing inulin or FOS, in vivo experiments support the
bifidogenic effect of FOS with large variations depend-
ing on the subjects, faecal microflora composition, doses
and categories of FOS and/or inulin (9,10). Authors no-
ted the end of the prebiotic effect and the decrease of co-
lonic microflora when the addition of FOS in food was
stopped (20).
The GOS and TGOS fermentations are also well do-
cumented. TGOS are GOS produced by transgalactosy-
lation of lactose using a b-galactosidase. In the final pro-
duct, different linkages between the galactose and the
reducing terminal glucose have been identified [(1,2);
(1,3) and (1,4)] and branched glucose residues occur. The
galactan fragment is (1,4) or (1,6) linked as for GOS (21,
22). This high degree of variability in glycosidic linkage
could implicate an incomplete resistance to gastric acid-
ity and mammalian enzymes, as suggested by Tomoma-
tsu (23). Generally, studies of the impact of TGOS on co-
lic microflora species have shown that if many strains of
enteric bacteria are unable to metabolise TGOS, Bifido-
bacteria and in a minor rate Lactobacilli will metabolise
them (24). Bifidobacterium adolescentis, one of the predo-
minant human faecal bacterium, can degrade and me-
tabolise TGOS with DP 3 or higher, contrary to Bifido-
bacterium infantis and Lactobacillus acidophilus, which can
use only TGOS with DP 3. This particularity is related to
a b-galactosidase probably attached to the membrane (25).
GOS metabolism was also investigated with fractionated
GOS used as substrate for Bacillus lactis and for Lacto-
bacillus rhamnosus by Gopal et al. (26), who noted that B.
lactis, contrary to L. rhamnosus, was able to metabolise
tri- and tetrasaccharidic fractions, suggesting a specific
transport system. Data from in vivo experiments con-
firmed the increase of Bifidobacteria and Lactobacilli when
TGOS were added in foods (27,28).
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XOS, IMO and SOS prebiotics
Compared to FOS and GOS/TGOS, other prebiotic
oligosaccharides are less documented, except for xylo-
oligosaccharides (XOS), isomaltooligosaccharides (IMO),
soybean oligosaccharides (SOS) and lactulose. However,
even if the lactulose, resulting from the isomerisation of
lactose to form galactosyl b-(1,4) fructose, is well known
as a prebiotic oligosaccharide, its status in the oligosac-
charide nomenclature (IUB-IUPAC) is not well established.
Moreover, considering the possible lactose isomerisation
during food engineering and notably during heat treat-
ment of milk, this disaccharide may be naturally present
in significant concentrations in food products. Neverthe-
less, in vitro comparative data showed that lactulose is
one of the most efficient prebiotics in Bifidobacteria strains
(13). Comparative results were found with in vivo exper-
iments (29–31).
Considering XOS, IMO and SOS, their first commer-
cial uses as prebiotics are presently being developed in
Japan. Like the xylan, XOS are very resistant to acids
and mammalian enzymes. They are manufactured by
xylanase degradation of xylans and lead to an oligome-
ric mix where the xylobiose is the most representative
compound (32). Data relating to XOS metabolism by in-
testinal microflora are ambiguous and Gibson et al. (10)
concluded their recent review without the classification
of XOS, as their fermentation does not seem to be selec-
tive (33,34).
Like XOS, IMO have a real positive effect, resulting
in higher populations of Bifidobacteria (10,11,13,35). How-
ever, these a-(1,4)(1,6) oligoglucans produced from starch
hydrolysis by a-amylases and pullulanases are poten-
tially digestible by mammalians and can be metabolised
by a wide range of bacteria. Consequently, their belong-
ing to prebiotic oligosaccharides is not actually really de-
fined (10).
The soybean oligosaccharides (raffinose and stachy-
ose) are well known a-galactosyl sucrose derivatives ex-
tracted from soybeans (11,12). They are present in soy-
germ powder, whose fermentation properties have been
successfully tested on Lactobacilli in the SHIME with fae-
cal bacteria inoculum (11). A comparative in vitro evalu-
ation of SOS on predominant gut bacterial groups showed
that SOS have comparable effects with other galactooli-
gosaccharides (12). On pure cultures, similar results have
been obtained with individual purified compounds or
mixture of oligosaccharides (36).
New prebiotic oligosaccharides
At present, the advancement of knowledge about
polysaccharides from plant cell wall and plant cell wall
polysaccharide cleavage enzymes allows the develop-
ment of novel prebiotics. Effectively, these polysaccha-
rides are available in large amounts notably from food
industry by-products. Therefore, the use of specific hy-
drolysis conditions leads to processes for oligosaccha-
ride productions. These oligomers have a large variety
of structures and could become an interesting way to in-
crease the value of plant by-products in the future. We
noted that some of these oligomers are naturally pro-
duced during processing of food where glycanases are
used for technological benefit.
In this way, arabinogalactooligosaccharides, arabino-
xylooligosaccharides, arabinooligosaccharides, galactu-
ronan oligosaccharides, rhamnogalacturonan oligosaccha-
rides and pectic oligosaccharides have been successfully
experimented with (25,37–39). These oligomers have been
fermented in pure cultures by intestinal bacteria such as
Bifidobacteria, Lactobacilli, Bacteroides sp., Clostridium sp.,
Escherchia coli and Klebsiella sp.
In addition, recent literature has detailed numerous
other oligosaccharidic structures as glucooligosaccharides
and oligosaccharides from melibiose, mannan oligosac-
charides, oligodextrans and gentiooligosaccharides with
prebiotic activities (13,38,40,41). We also noted that some
probiotic bacteria could produce by themselves polysac-
charides (but no oligosaccharides) having prebiotic ef-
fects (42).
Use of prebiotics for additional beneficial effects
As classical prebiotic oligosaccharides added in food,
human milk oligosaccharides stimulate the proliferation
of bifidogenic microflora in breastfed children (43), but
have also other important roles in the local intestine im-
mune system (44). They play a role of additional de-
fence mechanism as receptors (45) or block the progress
of inflammatory responses (46). All these functions de-
tected for sialylated and fucosylated oligosaccharides
from human milk have not yet been tested with com-
mercial FOS or GOS, but it is possible that these com-
pounds have these effects as well.
Moreover, in addition to the increase of Bifidobacteria
and Lactobacilli, prebiotic oligosaccharides have other
identified effects that could enhance their use for thera-
peutic actions. One of them is the detection of short
chain fatty acid (as propionate or butyrate) production
as end fermentative products. These compounds have
been recognised for their role in the prevention of colon
cancer (47). It is also reported that FOS significantly in-
crease the effects of different cytotoxic drugs used in hu-
man cancer treatment (48).
The proliferation of beneficial bacteria under the in-
fluence of prebiotic oligosaccharides has also a signifi-
cant impact on the prevention of the proliferation of pa-
thogenic bacteria. This has been attributed to the low
pH environment created during the fermentation of FOS
in the colon (49).
Other data described a role of FOS in mineral ab-
sorption (mainly magnesium and calcium) because of
the pH decrease in colon during their fermentation (50).
The role of FOS in the control of diabetes has also been
suggested (51). However, the important rate of residual
monosaccharides in commercial FOS limits their uses in
diabetic food products. FOS have also been implicated
in the lipid metabolism and a lot of data suggest that
FOS in foods modify the hepatic metabolism of lipids
(52), inhibit secretion of triacylglycerol (TAG)-rich very
low density lipoproteins (VLDL) (9) and reduce blood
levels of TAG (53). FOS are also known to decrease the
cholesterol in insulin-independent diabetic patients (54).
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Oligosaccharides As Natural Food Preservatives
The term biopreservative includes a wide range of
natural products from both plants and microorganisms,
able to extend shelf life of foods, reduce or eliminate sur-
vival of pathogenic bacteria and increase overall quality
of food products (55). These natural occurring antimi-
crobials can be, for example, peptides such as bacterio-
cins (56,57) or lipophilic substances such as essential oils
(58). Compared to these two kinds of antimicrobial mol-
ecules, sugar molecules seem to be less investigated as
potential food preservatives.
In this context, one of the currently most studied po-
lysaccharides is indisputably chitin. This linear homopo-
lymer of b-(1,4)-linked-N-acetyl-D-glucosamine residues
(Fig. 1) is one of the most abundant renewable natural
polymers, second to cellulose. Chitin is commonly found
in the exoskeletons or cuticles of many invertebrates like
crustaceans and arthropods, in the cell walls of most
fungi and is extracted commercially from shellfish wastes
(59). As it is estimated to be synthesised in nature at a
level of up to 109–1010 tonnes a year, the potential of chi-
tin is evident in various industrial fields. Because of its
limited solubility in aqueous solutions and organic sol-
vents, many studies were realised on its low acetylated
form, called chitosan (Fig. 1c). This biopolymer is easily
obtained by alkali N-deacetylation of chitin. Polycationic
at pH=6, biodegradable, nontoxic, soluble in acetic acid
solutions, chitosan offers properties with great potential
for many industrial applications. Accordingly, chitosan
attracted considerable attention since it has been report-
ed to exhibit interesting activities, notably to improve
human health (60) and food quality with its antioxida-
tive (61) and antimicrobial (62,63) properties. Moreover,
concerning this last point and with respect to antimicro-
bial activity, chitosan seems superior to chitin since it con-
tains amino groups which could interact with the nega-
tively charged bacterial cell membranes and then inhibit
the bacterial growth (64–67). Other mechanisms for anti-
microbial activity of chitosan have also been suggested,
as the blockage of RNA transcription by adsorption of
penetrated chitosan to bacterial DNA (68) or the chelat-
ing action of chitosan with metal trace elements or es-
sential nutrients, leading to microbial growth inhibition
(69).
Use of chitosan as potential food preservative
Most commercial native chitosans have a degree of
deacetylation greater than 70 % and a molecular mass
ranging between 100 and 1200 kDa. The legislation about
their uses as food additives varies according to the
country. Chitosan is sold in the European market in the
form of dietary capsules to assist mass loss; it is report-
edly used in Japan as a preservative in many food prod-
ucts (6,70), whereas the United States Food and Drug
Administration (USFDA) approved its use in 1983 only
as a feed additive (71) and has recently recognized it as
a GRAS (Generally Recognised As Safe) component (72).
Chitosan antioxidative activities
Several studies reported antioxidative activities ex-
hibited by chitosan. As the use of molecules with such
properties is one way to extend the shelf life of food
products, this biopolymer was tested on muscle foods,
such as meat or seafoods, which contain highly unsatu-
rated fatty acids particularly sensitive to oxidative change
during storage (61). St. Angelo (73) reported that iron
bound to proteins such as myoglobin or haemoglobin
can be released during postharvest storage and cooking
and then activate oxygen and initiate lipid oxidation.
The mechanism involved in chitosan antioxidative activ-
ity is thought to be related to chelation of free iron. Ef-
fectiveness of chitosan treatment on oxidative stability
of beef was also studied by Darmadji and Izumimoto
(74) who observed that the addition of chitosan at 1 %
concentration decreased the 2-thiobarbituric acid value
of meat for 70 % after three days of storage at 4 °C.
Chitosan antimicrobial activities
Antimicrobial activities of chitosan were also dem-
onstrated against many different kinds of microorgan-
isms. Accordingly, chitosan was shown to inhibit food
spoilage microorganisms, such as Candida sp., Escherichia
coli and Staphylococcus aureus (74,75). However, as the
culture media employed poorly represent what really
happens in complex food systems, this polysaccharide
has also been tested in food products. Several studies
were realized in fruit juices and emulsified sauces, but
also in solid foods such as meat (74,76), mayonnaise
(66,77), tofu (78), houmous and chilled salads (75). Final-
ly, chitosan was also studied as an edible antimicrobial
film to cover fresh fruits and vegetables (79), pizza (80)
and meat (81).
Properties of chitosan oligosaccharides
If all the investigated studies recognize the antimi-
crobial activities of chitosan, those seem to depend on
many factors, such as molecular mass, degree of acetyl-
ation, type of screened microorganisms and tested envi-







































Fig. 1. Structures of (a) cellulose, (b) chitin and (c) chitosan
ronmental conditions (82). Accordingly, DP is one of the
most investigated factors. Finally, chitosan oligomers have
received considerable attention since they were reported
to be able to exhibit biological activities as interesting as
those of their corresponding polymers even if the results
about it are still controversial. In this way, No et al. (78)
examined the antibacterial activities against several spoil-
age and food-borne bacteria of six chitosans and chito-
san oligomers with widely different molecular mass. Their
results led them to conclude that chitosans have higher
antibacterial activities and markedly inhibited growth of
most tested bacteria at a 0.1 % concentration. On the other
hand, Tsai et al. (83) evaluated the antibacterial activity
of a mixture of chitooligosaccharides prepared by diges-
tion of shrimp chitosan against food-borne bacteria in
nutrient broth. They showed that the required chitooli-
gosaccharide mixture concentration to reach bactericidal
effect on the tested bacteria was lower than that re-
quired with native chitosan. As to Kittur et al. (84), they
showed that the growth inhibitory effect of a chitooli-
gosaccharide preparation with DP ranging from 2 to 6
was better than that of native chitosan.
For their part, Rhoades and Roller (75) investigated
the antimicrobial actions in laboratory media of degrad-
ed and native chitosans against spoilage microorganisms.
They proved that the inhibitory activity of chitosan against
spoilage yeasts such as Zygosaccharomyces bailii and Sac-
charomyces cerevisiae was enhanced with chitosan degra-
dation products. Tsai et al. (85) showed that LMM chi-
tosan (12 kDa) has much higher antimicrobial activity
than the mixture of chitooligosacharides (DP 1 to 8)
against pathogenic microorganisms. In the same way Kit-
tur et al. (84) demonstrated that the inhibition percent-
age of Bacillus cereus growth doubled from chitooligo-
saccharides trimer to hexamer at 10 % concentration. All
these results were in agreement with those of Kendra
and Hadwinger (86), who demonstrated that, if chito-
oligosaccharides can exhibit strong antibacterial effect, it
is nevertheless greatly dependant on their DP and re-
quires glucosamine oligomers with DP 7 or greater.
In addition, environmental conditions and the nature
of food products seem to influence the antimicrobial ac-
tivity of chitosan and chitosan oligomers. Accordingly,
Savard et al. (65) reported different inhibition patterns in
liquid and solid media for chitosan oligomers tested
against yeasts. Unlike previous results, the inhibitory ac-
tivity of chitosan oligomers in agar medium was lost
with the increase of the DP. As in liquid medium, the in-
termediate molecular mass chitosans were more toxic
than the low molecular mass ones; the authors con-
cluded that medium composition influenced the inhibi-
tory activity of chitosan oligomers. Rhoades and Roller
(75) explained the differences observed by the nature of
solid medium which could restrict the mass transfer of
macromolecules. Then, the choice of the food product to
preserve from spoilage with chitosan or chitosan oligo-
mers has to be judicious in order to keep a maximal
antimicrobial activity. In the case of food products that
need the use of microorganisms, such as lactic or vege-
table fermentation, the antimicrobial action of chitosan
or chitosan oligosaccharides may not permit their uses.
Nonetheless, it can be conceivable to add them before
packaging, in order to fight against spoilage yeasts (65).
Concerning the pH effects on various molecular mass
chitosans, it affected their antibacterial activity indepen-
dently of their molecular mass (78). This result clearly
indicates that, whatever their molecular mass, applica-
tions of chitosans or chitosan oligomers in acidic food
products would enhance their effectiveness.
Oligosaccharide Engineering
Even if the potentialities of oligosaccharides are
real, in most cases the lack of oligosaccharide produc-
tion processes is the main drawback limiting their appli-
cations. That is why the development of oligosaccharide
engineering strategies actually represents a challenge.
Bioactive oligosaccharides come from oligomer en-
gineering with either (i) synthesis (using enzymatic or
chemical engineering) or (ii) polysaccharide depolymeri-
zation (using physical, chemical or enzymatic methods).
Chemical and biochemical synthesis of oligosaccharides
The chemical or biochemical synthesis of oligosac-
charidic structures is much more difficult than it was ob-
served in the synthesis processes of other biopolymers
such as peptides and nucleic acids because of the higher
number of possibilities in monomeric unit combinations.
So, the stereospecific introduction of glycosidic linkages
appears as the challenge of oligosaccharide synthesis.
Nevertheless, recent advances in enzymatic and chemi-
cal synthesis allow envisaging the preparation of a wide
range of oligomers.
Chemical glycosylation in the production of
oligosaccharides
Different strategies have been published for the che-
mical synthesis of oligosaccharides (87,88). Generally, the
preparation of oligomers by chemical processes takes
place as illustrated in Fig. 2. The glycosylation reaction
is achieved by an inter-glycosidic condensation between
a completely protected glycosyl donor (R-OH) that has
an excellent leaving group (halogenides) at its anomeric
position and a glycosyl acceptor that possesses only one
free hydroxyl group. Among these glycosyl donors, the
anomeric fluorides, trichloroacetimidates and thioglyco-
sides (Fig. 3) are currently being employed (87). These
compounds can be prepared under mild conditions and
are sufficiently stable to be purified and stored for a con-
siderable period of time. The preparation of specific gly-
cosyl donor and acceptor implies many protection and
deprotection steps to combine high yields with regio-
and stereoselectivity. With these strategies oligosaccha-
rides of interest such as oligogalacturonides (OGAs) have
been synthetised (89,90). These compounds used as gly-
cosylation intermediates should permit the production
of higher oligomers of D-galacturonates. Likewise, other
oligomers as for example, xylooligosaccharides (DP 4 up
to 10) have also been generated by a complex blockwise
synthesis approach (91). These syntheses show that the
formation of oligosaccharides is only possible when each
step in the assembly of the glycosyl (donor and accep-
tor) is high yielding.
Therefore, in spite of recent developments, synthesis
of oligosaccharides by chemical glycosylations seems ac-
tually nonrealistic for industrial processes. Conversely,
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other chemical alternative methods such as chemome-
chanical synthesis of bifidogenic glucooligosaccharides
have been successfully tested by extrusion process (92).
Enzymatic glycosylation in the production
of oligosaccharides
The large-scale productions of oligosaccharides thanks
to enzymatic synthesis have largely been developed these
last decades. Effectively, specific studies of biosynthesis
pathways of oligosaccharides and the use of glycosida-
ses and glycosyltransferases permit to avoid the disad-
vantages of chemical methods, since the enzymes con-
trol both regio- and stereoselectivity of glycosylation.
Glycosyltransferases (E.C. 2.4.xy) catalyse the trans-
fer of sugar moieties from activated donor molecules to
specific acceptor molecules, forming glycosidic bonds
(Fig. 4). These enzymes are highly regio- and stereose-
lective and have been obtained after purification or after
cloning and overexpression.










































































Fig. 2. Current strategy of the chemical synthesis of oligosaccharides (R: H or saccharides)
Glycosylhydrolases (E.C. 3.2.1.-) are much more
readily available than glycosyltransferases but are gener-
ally less stereoselective. These specific biocatalysts were
traditionally used for the degradation of poly- and oligo-
saccharides. Nevertheless, the reverse hydrolytic activities
under suitable reaction conditions and the utilizations of
nucleotide-activated sugars permit the formation of gly-
cosidic bond (Fig. 5a). Yields were generally lower with
glycosidases except with mutated derivative named gly-
cosynthase that operates more efficiently with appropri-
ated activated glycosyl donors such as fluorides (Fig. 5b).
Many bioactive oligosaccharides are produced by the
enzymatic engineering such as FOS from sucrose using
fructosyltransferase (9), TOS or GOS from lactose using
b-galactosidase (93) and gentiooligosaccharides from
glucose by transglucosylation (94).
Finally, note the possibility to produce isomaltooli-
gosaccharides, galactooligosaccharides and fructooligo-
saccharides using immobilized dextransucrase, galacto-
sidase and fructosyltransferase, respectively (95–97).
Polysaccharide depolymerization
Except for chemical treatments with acid and radi-
cal hydrolysis (Fig. 6) or physical treatments using ther-
mal, microwave, g-irradiation and ultrasonication deg-












































































Fig. 6. Reactional mechanism of (a) radical and (b) acid polysaccharide depolymerization (R: H or saccharide)
radations, the enzymatic depolymerization is the main
approach to prepare large amounts of oligomers.
The largely found strategies are microbiotechnology
procedures that degrade various polysaccharides using
regio- and stereospecifically microbial enzymes such as
polysaccharide hydrolases and polysaccharide lyases.
The polysaccharide hydrolases (E.C. 3.2.1.-) catalyze the
hydrolysis of the glycosidic bonds via a general acid ca-
talysis requiring two critical residues: a proton donor
and a nucleophile/base. This hydrolysis occurs via two
mechanisms giving rise to either an overall retention or
an inversion of anomeric configuration. Concerning po-
lysaccharide lyases (E.C. 4.2.2.-), they constitute a spe-
cific group of enzymes which generate the cleavage of
polysaccharide chains via a b-elimination resulting in
the formation of a double bond at the newly formed
non-reducing end (Fig. 7).
Actually, these selective biocatalysts are largely ex-
ploited and developed to prepare a majority of bioactive
oligosaccharides. In this manner, several oligosaccha-
rides with bifidogenic application were commercially
prepared (94); for example, maltooligosaccharides from
starch using a-amylases, isomaltooligosaccharides with
the action of a,b-amylases and a-glucosidases, fructooli-
gosaccharides from enzymatic hydrolysis of inulin, and
xylooligosaccharides from xylan cleavage with b-(1,4)
xylanases. In addition, pectinases, pectate lyases and
other polygalacturonases (98) were used to generate oli-
gogalacturonides from pectin cleavage.
Conclusion
The expansion of the knowledge of new oligosac-
charidic structures, associated with the advances of gly-
cobiotechnologies, could authorize a larger employment
of these compounds as food ingredients in the future.
The expansion of this market implies strategies for their
low cost manufacturing. Even if the recent advances in
polysaccharide cleavage enzymes and in the microorga-
nisms are applied to generate some oligosaccharides in
large scale, the improvement of glycosylation strategies
(chemical or biochemical) seems to be much more prom-
ising and reliable in the manufacture of oligosaccharides
and derivatives. Many di-, tri- and tetrasaccharides can
be now synthesized routinely involving a minimum num-
ber of glycosylation steps and solid phase oligosaccha-
ride synthesis is developed. It consequently opens the
way to original oligomer preparations notably in regard
to advances of automated systems. Nonetheless, as these
methods are limited, chemists and biochemists focus on
the preparation of large amounts of more oligosaccha-
rides using enzymatic polysaccharide depolymerization.
In this way, the chitinous biooligomers offer a wide
range of unique applications to prevent foods from mi-
crobial deterioration. As they are able to exhibit interest-
ing antioxidative and antimicrobial activities, they may
be of advantageous use in the field of natural food addi-
tives. Considering the prebiotic oligosaccharides, the un-
derstanding of structure-function relationships related to
probiotic bacteria targets could move the research to-
wards specific structures with a higher level of function-
ality. Additionally, the screening of new oligosaccharidic
structures and notably those obtained after bacterial po-
lysaccharide degradations could enhance the prebiotic
oligosaccharide families. Effectively, bacterial polysac-
charide as exopolysaccharides offer a large range of
structures and are produced in controlled conditions (re-
actors). So their degradations by specific enzymes will
offer, in the future, numerous oligosaccharides with po-
tentialities as prebiotics. Moreover, the next generations
of prebiotic oligosaccharides could be supplied by pro-
biotics themselves. Effectively, a part of Lactobacilli are
exopolysaccharide-producing strains and no data have
been reported related to the prebiotic activity of oligo-
mers that come from them even if the polymeric pat-
terns as levans are known as having prebiotic effects.
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